Botulinum A toxin

Applied filters

Safety in Lactation: Antimigraine drugs

21 October 2020If simple analgesics, e.g. paracetamol and ibuprofen, are insufficient to treat symptoms, sumatriptan is the drug of choice for the treatment of acute migraine. Although…

MHRA guidance on Supply and administration of Botox®, Vistabel®, Dysport® and other injectable medicines in cosmetic procedures

8 September 2020As well as covering such questions as who can administer these medicines and who is an appropriate practitioner, this guidance refers to administration of these…

Safety in Lactation: Drugs for movement disorders

10 November 2018Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance.  Drugs for dystonias and other involuntary…

Hypersalivation – what drug treatment options are available?

1 August 2018This Medicines Q&A is one of a series of five Q&A documents to address the drug treatment of hypersalivation (drooling or sialorrhoea). It gives a…

Hypersalivation – what are the treatment alternatives to glycopyrronium and hyoscine?

1 August 2018This Medicines Q&A outlines possible alternatives to hyoscine hydrobromide and glycopyrronium in the treatment of non drug-induced hypersalivation, e.g. botulinum toxin, amitriptyline, atropine (eye drops…

Drug-induced hypersalivation – what treatment options are available?

1 August 2018This Medicines Q&A summarises published studies or case reports concerning the pharmacological treatment of drug-induced hypersalivation (drooling or sialorrhoea), particularly hypersalivation caused by clozapine. Update…